biotech · Advanced Solid Tumor · Solid Tumor, Adult · IMMX
Immix Biopharma
Immix Biopharma patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Los Angeles, USA HQ
2012 Founded
39 Employees
Public company Type
IMMX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Los Angeles, USA
- Founded
- 2012
- Employees
- 39
- Programs
- 3
- Drugs
- 2
- Patents
- 2
Immix Biopharma patents
2 pharmaceutical patents indexed for Immix Biopharma. 0 expire within 24 months.
Immix Biopharma has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Immix Biopharma have?
2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Immix Biopharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.